Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Mannaerts

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
F&S Reports|May 24, 2023
Ganirelix and the prevention of premature luteinizing hormone surgesBernadette Mannaerts
Reproductive Biomedicine Online|May 21, 2022
Response to: Comparison between follitropin delta and follitropin alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!Bernadette Mannaerts
Fertility and Sterility|March 31, 2012
Comment on, "Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis"Bernadette Mannaerts, Pierre Verweij, Keith Gordon
Reproductive Biomedicine Online|April 28, 2025
Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical researchBernadette Mannaerts, Claus Yding Andersen, Colin M Howles
Human Reproduction (Oxford, England)|April 10, 2010
Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulationMaryse Bonduelle, Janine Oberyé, Bernadette Mannaerts, et al.
Reproductive Biomedicine Online|February 6, 2010
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cyclesKevin Doody, Paul Devroey, Keith Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2013
First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive ageMireille Gerrits, Bernadette Mannaerts, Hester Kramer, et al.
Human Reproduction (Oxford, England)|November 9, 2012
High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocolHuman M Fatemi, Kevin Doody, Georg Griesinger, et al.
Reproductive Biomedicine Online|July 18, 2025
A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserveJuan Antonio García-Velasco, Manuel Fernández-Sánchez, Per Larsson, et al.
Journal of Assisted Reproduction and Genetics|July 13, 2021
Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin deltaJon Havelock, Anna-Karina Aaris Henningsen, Bernadette Mannaerts, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
F&S Reports|May 24, 2023
Ganirelix and the prevention of premature luteinizing hormone surgesBernadette Mannaerts
Reproductive Biomedicine Online|May 21, 2022
Response to: Comparison between follitropin delta and follitropin alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!Bernadette Mannaerts
Fertility and Sterility|March 31, 2012
Comment on, "Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis"Bernadette Mannaerts, Pierre Verweij, Keith Gordon
Reproductive Biomedicine Online|April 28, 2025
Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical researchBernadette Mannaerts, Claus Yding Andersen, Colin M Howles
Human Reproduction (Oxford, England)|April 10, 2010
Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulationMaryse Bonduelle, Janine Oberyé, Bernadette Mannaerts, et al.
Reproductive Biomedicine Online|February 6, 2010
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cyclesKevin Doody, Paul Devroey, Keith Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2013
First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive ageMireille Gerrits, Bernadette Mannaerts, Hester Kramer, et al.
Human Reproduction (Oxford, England)|November 9, 2012
High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocolHuman M Fatemi, Kevin Doody, Georg Griesinger, et al.
Reproductive Biomedicine Online|July 18, 2025
A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserveJuan Antonio García-Velasco, Manuel Fernández-Sánchez, Per Larsson, et al.
Journal of Assisted Reproduction and Genetics|July 13, 2021
Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin deltaJon Havelock, Anna-Karina Aaris Henningsen, Bernadette Mannaerts, et al.
Pageof 4